ADVI director, Becca Davison, spoke with Morning Consult about defining value for pharmaceuticals and which factors are important to include in the process
Becca Davison, director at health care advisory company ADVI Health and former director at the Pharmaceutical Research and Manufacturers of America, said some of the more rote, formulaic ways that have been used to place “value” on drugs in the past have failed to take into account metrics that are important to society, such as quality of life and the overall effect on the health care system.
[el-text]
Written by Yusra Murad
***excerpt***
Becca Davison, director at health care advisory company ADVI Health and former director at the Pharmaceutical Research and Manufacturers of America, said some of the more rote, formulaic ways that have been used to place “value” on drugs in the past have failed to take into account metrics that are important to society, such as quality of life and the overall effect on the health care system.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.